BASLER AG (BSL.DE) Fundamental Analysis & Valuation

FRA:BSL • DE0005102008

Current stock price

18.42 EUR
+0.04 (+0.22%)
Last:

This BSL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. BSL.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BSL was profitable.
  • In the past year BSL had a positive cash flow from operations.
  • In multiple years BSL reported negative net income over the last 5 years.
  • In the past 5 years BSL always reported a positive cash flow from operatings.
BSL.DE Yearly Net Income VS EBIT VS OCF VS FCFBSL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

1.2 Ratios

  • BSL has a better Return On Assets (4.89%) than 80.85% of its industry peers.
  • BSL has a Return On Equity of 8.76%. This is in the better half of the industry: BSL outperforms 74.47% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.79%, BSL is in the better half of the industry, outperforming 70.21% of the companies in the same industry.
Industry RankSector Rank
ROA 4.89%
ROE 8.76%
ROIC 6.79%
ROA(3y)-2.23%
ROA(5y)2.13%
ROE(3y)-4.21%
ROE(5y)3.74%
ROIC(3y)N/A
ROIC(5y)N/A
BSL.DE Yearly ROA, ROE, ROICBSL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • BSL's Profit Margin of 5.25% is fine compared to the rest of the industry. BSL outperforms 74.47% of its industry peers.
  • In the last couple of years the Profit Margin of BSL has declined.
  • BSL has a better Operating Margin (7.98%) than 76.60% of its industry peers.
  • BSL's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 47.99%, BSL is doing good in the industry, outperforming 68.09% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BSL has declined.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.25%
GM 47.99%
OM growth 3Y-7.68%
OM growth 5Y-6.3%
PM growth 3Y-12.71%
PM growth 5Y-9.97%
GM growth 3Y-0.46%
GM growth 5Y-1.6%
BSL.DE Yearly Profit, Operating, Gross MarginsBSL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

7

2. BSL.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BSL is destroying value.
  • BSL has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BSL has more shares outstanding
  • BSL has a better debt/assets ratio than last year.
BSL.DE Yearly Shares OutstandingBSL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
BSL.DE Yearly Total Debt VS Total AssetsBSL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • BSL has an Altman-Z score of 5.19. This indicates that BSL is financially healthy and has little risk of bankruptcy at the moment.
  • BSL has a better Altman-Z score (5.19) than 78.72% of its industry peers.
  • BSL has a debt to FCF ratio of 3.30. This is a good value and a sign of high solvency as BSL would need 3.30 years to pay back of all of its debts.
  • BSL has a Debt to FCF ratio of 3.30. This is in the better half of the industry: BSL outperforms 68.09% of its industry peers.
  • BSL has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.38, BSL is in line with its industry, outperforming 44.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 3.3
Altman-Z 5.19
ROIC/WACC0.98
WACC6.93%
BSL.DE Yearly LT Debt VS Equity VS FCFBSL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 2.17 indicates that BSL has no problem at all paying its short term obligations.
  • BSL has a Current ratio of 2.17. This is in the better half of the industry: BSL outperforms 74.47% of its industry peers.
  • BSL has a Quick Ratio of 1.53. This is a normal value and indicates that BSL is financially healthy and should not expect problems in meeting its short term obligations.
  • BSL has a Quick ratio of 1.53. This is amongst the best in the industry. BSL outperforms 80.85% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 1.53
BSL.DE Yearly Current Assets VS Current LiabilitesBSL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. BSL.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 184.33% over the past year.
  • Measured over the past years, BSL shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.55% on average per year.
  • The Revenue has grown by 19.92% in the past year. This is quite good.
  • BSL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.41% yearly.
EPS 1Y (TTM)184.33%
EPS 3Y-19.12%
EPS 5Y-5.55%
EPS Q2Q%107.81%
Revenue 1Y (TTM)19.92%
Revenue growth 3Y-6.45%
Revenue growth 5Y5.41%
Sales Q2Q%16.28%

3.2 Future

  • The Earnings Per Share is expected to grow by 36.06% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, BSL will show a quite strong growth in Revenue. The Revenue will grow by 10.47% on average per year.
EPS Next Y35.54%
EPS Next 2Y36.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.61%
Revenue Next 2Y12.17%
Revenue Next 3Y11.46%
Revenue Next 5Y10.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BSL.DE Yearly Revenue VS EstimatesBSL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
BSL.DE Yearly EPS VS EstimatesBSL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

3

4. BSL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 48.47, which means the current valuation is very expensive for BSL.
  • BSL's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.35. BSL is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 33.36, BSL can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BSL.
  • The average S&P500 Price/Forward Earnings ratio is at 22.23. BSL is valued rather expensively when compared to this.
Industry RankSector Rank
PE 48.47
Fwd PE 33.36
BSL.DE Price Earnings VS Forward Price EarningsBSL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BSL is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BSL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 29.21
EV/EBITDA 16.64
BSL.DE Per share dataBSL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • BSL's earnings are expected to grow with 36.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.36
PEG (5Y)N/A
EPS Next 2Y36.06%
EPS Next 3YN/A

1

5. BSL.DE Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.62%, BSL is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.61, BSL has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.62, BSL pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.62%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BSL.DE Yearly Dividends per shareBSL.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2026 0.5 1 1.5

5.3 Sustainability

DP0%
EPS Next 2Y36.06%
EPS Next 3YN/A
BSL.DE Yearly Income VS Free CF VS DividendBSL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

BSL.DE Fundamentals: All Metrics, Ratios and Statistics

BASLER AG

FRA:BSL (4/28/2026, 9:07:02 AM)

18.42

+0.04 (+0.22%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-31
Earnings (Next)05-06
Inst Owners22.84%
Inst Owner ChangeN/A
Ins Owners3.97%
Ins Owner ChangeN/A
Market Cap580.23M
Revenue(TTM)221.77M
Net Income(TTM)11.63M
Analysts85.71
Price Target22.1 (19.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.62%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.36%
PT rev (3m)2.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.38%
EPS NY rev (3m)-2.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.02%
Revenue NY rev (3m)2.02%
Valuation
Industry RankSector Rank
PE 48.47
Fwd PE 33.36
P/S 2.62
P/FCF 29.21
P/OCF 19.26
P/B 4.37
P/tB 12.22
EV/EBITDA 16.64
EPS(TTM)0.38
EY2.06%
EPS(NY)0.55
Fwd EY3%
FCF(TTM)0.63
FCFY3.42%
OCF(TTM)0.96
OCFY5.19%
SpS7.04
BVpS4.22
TBVpS1.51
PEG (NY)1.36
PEG (5Y)N/A
Graham Number6.00503 (-67.4%)
Profitability
Industry RankSector Rank
ROA 4.89%
ROE 8.76%
ROCE 9.48%
ROIC 6.79%
ROICexc 8.22%
ROICexgc 18.43%
OM 7.98%
PM (TTM) 5.25%
GM 47.99%
FCFM 8.96%
ROA(3y)-2.23%
ROA(5y)2.13%
ROE(3y)-4.21%
ROE(5y)3.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-3.36%
ROICexgc growth 5Y-8.81%
ROICexc growth 3Y-7.25%
ROICexc growth 5Y-7.51%
OM growth 3Y-7.68%
OM growth 5Y-6.3%
PM growth 3Y-12.71%
PM growth 5Y-9.97%
GM growth 3Y-0.46%
GM growth 5Y-1.6%
F-Score7
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 3.3
Debt/EBITDA 1.44
Cap/Depr 58.22%
Cap/Sales 4.63%
Interest Coverage 11.25
Cash Conversion 85.29%
Profit Quality 170.76%
Current Ratio 2.17
Quick Ratio 1.53
Altman-Z 5.19
F-Score7
WACC6.93%
ROIC/WACC0.98
Cap/Depr(3y)56.27%
Cap/Depr(5y)88.82%
Cap/Sales(3y)5.71%
Cap/Sales(5y)7.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)184.33%
EPS 3Y-19.12%
EPS 5Y-5.55%
EPS Q2Q%107.81%
EPS Next Y35.54%
EPS Next 2Y36.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.92%
Revenue growth 3Y-6.45%
Revenue growth 5Y5.41%
Sales Q2Q%16.28%
Revenue Next Year12.61%
Revenue Next 2Y12.17%
Revenue Next 3Y11.46%
Revenue Next 5Y10.47%
EBIT growth 1Y280.82%
EBIT growth 3Y-13.63%
EBIT growth 5Y-1.23%
EBIT Next Year145.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y254%
FCF growth 3YN/A
FCF growth 5Y-2.31%
OCF growth 1Y84.47%
OCF growth 3Y34.43%
OCF growth 5Y-4.19%

BASLER AG / BSL.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BASLER AG?

ChartMill assigns a fundamental rating of 5 / 10 to BSL.DE.


What is the valuation status of BASLER AG (BSL.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to BASLER AG (BSL.DE). This can be considered as Overvalued.


What is the profitability of BSL stock?

BASLER AG (BSL.DE) has a profitability rating of 5 / 10.


What is the financial health of BASLER AG (BSL.DE) stock?

The financial health rating of BASLER AG (BSL.DE) is 7 / 10.


What is the earnings growth outlook for BASLER AG?

The Earnings per Share (EPS) of BASLER AG (BSL.DE) is expected to grow by 35.54% in the next year.